| DATE |
Announcements |
| 16 Oct 2024 |
18 October 2024 is the last trading day of EKH-W1 |
| 02 Oct 2024 |
Rights of shareholders to propose 2025 AGM agenda and nominate director candidates |
| 19 Sep 2024 |
Trading Suspension and termination of listing status of EKH-W1 |
| 17 Sep 2024 |
Notification the final exercise and request for suspension of EKH-W1 |
| 19 Aug 2024 |
Clarifying the non-adjustment of warrant rights No. 1 (EKH-W1) |
| 15 Aug 2024 |
No Right Adjustment of EKH-W1 |
| 15 Aug 2024 |
Providing financial assistance to subsidiaries |
| 15 Aug 2024 |
Establishment of a subsidiary company |
| 14 Aug 2024 |
Interim dividend payment |
| 14 Aug 2024 |
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024 |
| 14 Aug 2024 |
Financial Performance Quarter 2 (F45) (Reviewed) |
| 30 Jul 2024 |
Report on the utilization of proceeds from the Capital Increase from Private Placement and the Exercising of EKH-W1 |
| 07 Jun 2024 |
New shares of EKH to be traded on June 10, 2024 |
| 04 Jun 2024 |
Report on the results of the Exercise of EKH-W1 (F53-5) |
| 30 May 2024 |
The information of the disposition of Investment in The Klinique Medical Clinic Public Company Limited (Update) |
| 24 May 2024 |
The information of the disposition of Investment in The Klinique Medical Clinic Public Company Limited |
| 24 May 2024 |
New shares of EKH to be traded on May 27, 2024 |
| 20 May 2024 |
Report on the result of stock dividend allocation (F53-5) |
| 13 May 2024 |
Submission of the Minutes of the 2024 Annual General Meeting of Shareholders to the Stock Exchange of Thailand and Publication on the Company’s Website |
| 13 May 2024 |
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024 |
| 10 May 2024 |
Financial Performance Quarter 1 (F45) (Reviewed) |
| 07 May 2024 |
Notification the exercise of EKH-W1 |
| 02 May 2024 |
Form to Report on Names of Members and Scope of Work of the Audit Committee (F24-1) |
| 26 Apr 2024 |
Shareholders meeting’s resolution |
| 27 Mar 2024 |
Publication of Invitation of Annual General Meeting of Shareholders for the Year 2024 on Company’s Website |
| 13 Mar 2024 |
Clarification of trading of Big Lot shares |
| 01 Mar 2024 |
Right Adjustment of EKH-W1 |
| 01 Mar 2024 |
Dividend payment, Right adjustment for warrants exercise and 2024 Annual Ordinary General Meeting of Shareholders (Revised) |
| 01 Mar 2024 |
|
| 29 Feb 2024 |
|
| 29 Feb 2024 |
Financial Performance Yearly (F45) (Audited) |
| 30 Jan 2024 |
Report on the utilization of proceeds from the Capital Increase from Private Placement and from the Exercising of EKH-W1 |
| 12 Dec 2023 |
|
| 08 Dec 2023 |
|
| 07 Dec 2023 |
|
| 01 Dec 2023 |
|
| 20 Nov 2023 |
|
| 14 Nov 2023 |
|
| 14 Nov 2023 |
|
| 14 Nov 2023 |
|
| 06 Nov 2023 |
|
| 31 Oct 2023 |
|
| 10 Aug 2023 |
|
| 10 Aug 2023 |
|
| 09 Aug 2023 |
Financial Performance Quarter 2 (F45) |
| 31 Jul 2023 |
Report on the utilization of proceeds from the Capital Increase from Private Placement and from the Exercising of EKH-W1 |
| 09 Jun 2023 |
New shares of EKH to be traded on June 12, 2023 |
| 06 Jun 2023 |
Report on the results of the Exercise of EKH-W1 (F53-5) |
| 23 May 2023 |
New shares of EKH to be traded on May 24, 2023 |
| 19 May 2023 |
Report on the result of stock dividend allocation (F53-5) |
| 11 May 2023 |
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2023 |
| 11 May 2023 |
Financial Performance Quarter 1 (F45) |
| 10 May 2023 |
Publication of the minutes of Annual General Shareholders Meeting for 2023 on the Company’s website |
| 03 May 2023 |
Notification the exercise of EKH-W1 |
| 25 Apr 2023 |
Shareholders meeting’s resolution |
| 28 Mar 2023 |
|
| 28 Feb 2023 |
Dividend payment, Right adjustment for warrants exercise and 2023 Annual Ordinary General Meeting of Shareholders (Revised F53-4) |
| 28-02-2023 |
Right Adjustment of EKH-W1 |
| 27-02-2023 |
Dividend payment, Right adjustment for warrants exercise and 2023 Annual Ordinary General Meeting of Shareholders (Revised F53-4) |
| 27-02-2023 |
Financial Statement Yearly 2022 (Audited) |
| 31-01-2023 |
Report on the utilization of proceeds from the Capital Increase from Private Placement and from the No.1 exercising of EKH-W1 |
| 22-11-2022 |
New shares of EKH to be traded on November 23, 2022 |
| 21-11-2022 |
Management Discussion and Analysis for the third quarter ending 30 September 2022 |
| 21-11-2022 |
Financial Statement Quarter 3.2022 |
| 17-11-2022 |
Report on the results of the Exercise of EKH-W1 (F53-5) |
| 11-11-2022 |
Financial Performance Quarter 3 (F45) |
| 11-08-2022 |
Financial Performance Quarter 2 (F45) (Reviewed) |
| 18-07-2022 |
Report on the results of sale of common shares offered to private placement (F53-5) |
| 12-07-2022 |
Determination of the subscription and payment date for the Company’s newly issued ordinary shares which is allocated to Private Placement |
| 11-07-2022 |
No Right Adjustment of EKH-W1 |
| 29-06-2022 |
Shareholders meeting’s resolution |
| 01-06-2022 |
No Right Adjustment of EKH-W1 |
| 23-05-2022 |
Board Resolution on Issuing Newly Ordinary Shares for Private Placement and Extraordinary General Meeting of Shareholders No.1/2022 (Revised No.3-Additional Agendas) |
| 23-05-2022 |
Resolution of 2022 Annual General Meeting (Edit the resolution of agenda 11) |
| 17-05-2022 |
Report on the result of stock dividend allocation (F53-5) |
| 12-05-2022 |
Financial Performance Quarter 1 (F45) (Reviewed) |
| 12-05-2022 |
Board Resolution on Issuing Newly Ordinary Shares for Private Placement and Extraordinary General Meeting of Shareholders No.1/2022 (More information) (Revised) |
| 11-05-2022 |
Publication of the minutes of Annual General Shareholders Meeting for 2022 on the Company’s website |
| 06-05-2022 |
Form to Report on Names of Members and Scope of Work of the Audit Committee (F24-1) |
| 03-05-2022 |
Right Adjustment of EKH-W1 |
| 29-04-2022 |
Board Resolution on Issuing Newly Ordinary Shares for Private Placement and Extraordinary General Meeting of Shareholders No.1/2022 (More information) |
| 27-04-2022 |
Board Resolution on Issuing Newly Ordinary Shares for Private Placement and Extraoordinary General Meeting of Shareholders No.1/2022 (Edit English File) |
| 27-04-2022 |
Board Resolution on Issuing Newly Ordinary Shares for Private Placement and Extroordinary General Meeting of Shareholders No.1/2022 |
| 27-04-2022 |
Shareholders meeting’s resolution |
| 19-04-2022 |
Dividend Payment, Right Adjustment for Warrants Exercise and 2022 Annual Ordinary General Meeting of Shareholders (Attached to the Capital Increase Report Form F53-4) |
| 04-04-2022 |
Publication of the 2022 Annual General Shareholders Meeting invitation on the company website |
| 02-03-2022 |
Dividend Payment, Right Adjustment for Warrants Exercise and 2022 Annual Ordinary General Meeting of Shareholders (Add template) |
| 25-02-2022 |
Dividend Payment, Right Adjustment for Warrants Exercise and 2022 Annual Ordinary General Meeting of Shareholders |
| 24-02-2022 |
Financial Performance Yearly (F45) (Audited) |
| 07-12-2021 |
Rights of shareholders to propose 2022 AGM agenda and nominate director candidates |
| 24-11-2021 |
Information Memorandum of the Warrants to Purchase the Ordinary Shares of Ekachai Medical Care Public Company Limited No. 1 (EKH-W1) |
| 19-11-2021 |
Report on the results of the sale of EKH-W1 offered to existing common shareholders (F53-5) (Edit Template) |
| 16-11-2021 |
Publication the minutes of the Extraordinary General Meeting of Shareholders No.1/2021 on the Company’s website |
| 15-11-2021 |
Report on the results of sale of EKH-W1 offered to existing common shareholders (F53-5) |
| 10-11-2021 |
Financial Performance Quarter 3 (F45) (Reviewed) |
| 29-10-2021 |
The information on investment the Acquisition of Shares in The Klinique Medical Clinic Public Company Limited (Revised) |
| 28-10-2021 |
The information on investment the Acquisition of Shares in The Klinique Medical Clinic Public Company Limited |
| 27-10-2021 |
Shareholders meeting’s resolution |
| 14-10-2021 |
Publication of the invitation letter for the Extraordinary General Meeting of Shareholders No. 1/2021 on the Company’s website |
| 20-09-2021 |
Issuance of Warrants to Purchase Ordinary Shares and the Date of Extraordinary General Meeting No. 1/2021 (Revised) |
| 17-09-2021 |
Issuance of Warrants to Purchase Ordinary Shares and the Date of Extraordinary General Meeting No. 1/2021 (Revised) |
| 17-09-2021 |
Issuance of Warrants to Purchase Ordinary Shares and the Date of Extraordinary General Meeting No. 1/2021 |
| 23-08-2021 |
Report Form for the Resale of Shares on the Stock Exchange dated 20 August 2021 |
| 20-08-2021 |
Report Form for the Resale of Shares on the Stock Exchange dated 19 August 2021 |
| 10-08-2021 |
Interim Dividend Payment |
| 10-08-2021 |
Financial Performance Quarter 2 (F45) (Reviewed) |
| 02-08-2021 |
Report on the Use of Proceeds from the Capital Increase as of June 30, 2021 |
| 09-07-2021 |
Report Form for the Resale of Shares on the Stock Exchange dated 9 July 2021 |
| 08-07-2021 |
Report Form for the Resale of Shares on the Stock Exchange dated 8 July 2021 |
| 08-07-2021 |
Report Form for the Resale of Shares on the Stock Exchange dated 7 July 2021 |
| 11-06-2021 |
Report Form for the Resale of Shares on the Stock Exchange dated 10 June 2021 |
| 02-06-2021 |
Report Form for the Resale of Shares on the Stock Exchange dated 1 June 2021 |
| 31-05-2021 |
Publication of the minutes of Annual General Shareholders Meeting for 2021 on the Company’s website |
| 13-05-2021 |
Financial Performance Quarter 1 (F45) (Reviewed) |
| 28-04-2021 |
Form to Report on Names of Members and Scope of Work of the Audit Commitee (F24-1) |
| 27-04-2021 |
Shareholders meeting’s resolution |
| 12-04-2021 |
Report Form for the Resale of Shares on the Stock Exchange dated 12 April 2021 |
| 09-04-2021 |
Report Form for the Resale of Shares on the Stock Exchange dated 9 April 2021 |
| 02-04-2021 |
Publication of the 2021 Annual General Shareholders Meeting invitation on the company website |
| 31-03-2021 |
Report Form for the Resale of Shares on the Stock Exchange (Revise Template) |
| 30-03-2021 |
Report Form for the Resale of Shares on the Stock Exchange |
| 25-02-2021 |
Notification of the period for resale of the Company’s repurchased shares under the share repurchase scheme (Treasury Stock) for financial management purposes |
| 25-02-2021 |
Financial Performance Yearly (F45) (Audited)(Revise) |
| 25-02-2021 |
Dividend Payment and 2020 Annual Ordinary General Meeting of Shareholders |
| 25-02-2021 |
Financial Performance Yearly (F45) (Audited) |
| 29-01-2021 |
Report on the Use of Proceeds from the Capital Increase as of December 31, 2020 |
| 15-Dec-2020 |
Change the business of a subsidiary |
| 01-Dec-2020 |
Rights of shareholders to propose 2021 AGM agenda and nominate director candidates |
| 11-Nov-2020 |
Financial Performance Quarter 3 (F45) (Reviewed) |
| 05-Oct-2020 |
Notification on the End of the Share Repurchase Project for Financial Management Purposes |
| 05-Oct-2020 |
Shares Repurchased Report dated 2 October 2020 |
| 02-Oct-2020 |
Shares Repurchased Report dated 1 October 2020 |
| 30-Sep-2020 |
Shares Repurchased Report dated 30 September 2020 |
| 29-Sep-2020 |
Shares Repurchased Report dated 29 September 2020 |
| 28-Sep-2020 |
Shares Repurchased Report dated 28 September 2020 |
| 28-Sep-2020 |
Shares Repurchased Report dated 25 September 2020 |
| 24-Sep-2020 |
Shares Repurchased Report dated 24 September 2020 |
| 23-Sep-2020 |
Shares Repurchased Report dated 23 September 2020 |
| 23-Sep-2020 |
Shares Repurchased Report dated 22 September 2020 |
| 21-Sep-2020 |
Shares Repurchased Report dated 21 September 2020 |
| 21-Sep-2020 |
Shares Repurchased Report dated 18 September 2020 |
| 18-Sep-2020 |
Shares Repurchased Report dated 17 September 2020 |
| 15-Sep-2020 |
Shares Repurchased Report dated 14 September 2020 |
| 10-Sep-2020 |
Shares Repurchased Report dated 10 September 2020 |
| 14-Aug-2020 |
Ratification of the connected transactions |
| 11-Aug-2020 |
Financial Performance Quarter 2 (F45) (Reviewed) |
| 29-Jul-2020 |
Report on the Use of Proceeds from the Capital Increase as of June 30, 2020 |
| 09-Jul-2020 |
Resolution of 2020 Annual General Meeting |
| 15-Jun-2020 |
Publication of the 2020 Annual General Shareholders Meeting invitation on the company website |
| 14-May-2020 |
Notification of resolutions setting forth the Annual Ordinary General Meeting of Shareholders in 2020 |
| 14-May-2020 |
Reviewed financial performance Quarter 1 (F45) |
| 13-May-2020 |
Reviewed financial performance Quarter 1 (F45) |
| 13-May-2020 |
The appointment of the auditors |
| 10-Apr-2020 |
Interim Dividend Payment |
| 10-Apr-2020 |
Notification of the postponement of the Annual General Meeting of Shareholders for the year 2020 and the Approval of Interim Dividend Payment |
| 30-Mar-2020 |
Publication of the 2020 Annual General Shareholders Meeting invitation on the company website |
| 19-Mar-2020 |
Resolution of the Board of Directors’ Meeting on the Share Repurchase Program for Financial Management |
| 27-Feb-2020 |
Dividend Payment and 2020 Annual Ordinary General Meeting of Shareholders |
| 27-Feb-2020 |
Audited Yearly financial performance (F45) |
| 31-Jan-2020 |
Report on the Use of Proceeds from the Capital Increase as of December 31, 2019 |
| 02-Dec-19 |
Rights of shareholders to propose 2020 AGM agenda and nominate director candidates |
| 29-Nov-2019 |
Opening of Children’s Center |
| 11-Nov-2019 |
Reviewed financial performance Quarter 3 (F45) |
| 14-Aug-2019 |
Establishment of New Subsidiary |
| 13-Aug-2019 |
Reviewed Quarter 2 and Consolidated F/S (F45-3) |
| 31-Jul-2019 |
Report on the Use of Proceeds from the Capital Increase as of June 30, 2019 |
| 15-May-2019 |
Clarification of Big Lot transaction |
| 15-May-2019 |
Appointment of new director and notification of changes in authorized signatories |
| 14-May-2019 |
Form to Report on Names of Members and Scope of Work of the Audit Committee (F24-1) |
| 13-May-2019 |
Reviewed Quarter 1 and Consolidated F/S (F45-3) |
| 25-Apr-2019 |
Shareholders meeting’s resolution |
| 26-Mar-2019 |
Publication of the 2019 Annual General Shareholders Meeting invitation on the company website |
| 21-Mar-2019 |
Notification of the Resignation of Director |
| 26-Feb-2019 |
Dividend Payment and 2019 Annual Ordinary General Meeting of Shareholders |
| 25-Feb-2019 |
Dividend Payment and 2019 Annual Ordinary General Meeting of Shareholders |
| 25-Feb-2019 |
Audited Yearly and Consolidated F/S (F45-3) |
| 30-Jan-2019 |
Report on the Use of Proceeds fromthe Capital Increase asof December 31, 2018 |
| 21-Dec-2018 |
Rights of shareholders to propose 2019 AGM agenda and nominate director candidates |
| 13-Nov-2018 |
The increase of shareholding proportion by buying of 23% newly issued common shares of Ekachai International Co., Ltd., which is Ekachai Medical Care PCL. subsidiary. |
| 12-Nov-2018 |
Reviewed Quarter 3 and Consolidated F/S (F45-3) |
| 09-Aug-2018 |
Reviewed Quarter 2 and Consolidated F/S (F45-3) |
| 31-Jul-2018 |
Report on the Use of Proceeds from the Capital Increase as of June 30, 2018 |
| 14-May-2018 |
Reviewed Quarter 1 and Consolidated F/S (F45-3) |
| 23-Apr-2018 |
Shareholders meeting’s resolution |
| 30-Mar-2018 |
Publication of the 2018 Annual General Shareholders Meeting invitation on the company website |
| 27-Feb-2018 |
Information Memorandum on Acquiring of Common Shares in Ekachai International Co., Ltd. (Revised) |
| 27-Feb-2018 |
Information Memorandum on Acquiring of Common Shares in Ekachai International Co., Ltd. |
| 26-Feb-2018 |
Dividend Payment and 2018 Annual Ordinary General Meeting of Shareholders |
| 26-Feb-2018 |
Audited Yearly and Consolidated F/S (F45-3) |
| 30-Jan-2018 |
Report on the Use of Proceeds from the Capital Increase as of December 31, 2017 |
| 08-Jan-2018 |
Opening of IVF center of Ekachai International Company Limited |
| 13-Dec-2017 |
Rights of shareholders to propose 2018 AGM agenda and nominate director candidates |
| 13-Nov-2017 |
Reviewed Quarter 3 and Consolidated F/S (F45-3) |
